Pleuropulmonary Blastoma - A Single Centre Experience
DOI:
https://doi.org/10.65129/surgical.v1i3.154Keywords:
Pediatric Lung Tumor, Pleuropulmonary Blastoma, PlombageAbstract
Background: Pleuropulmonary blastoma is a primary mesenchymal origin tumor of childhood with its origin in the thorax. It is considered a highly aggressive tumor because of its late diagnosis, potential for metastasis and recurrence and resistance to treatment. With very few series reported in literature and no standardized protocol, this tumor has become hard to treat. Materials and Methods: This series aims to study the cases that presented at our institute in terms of clinical presentation, work up, management and identify factors that can be associated with prognosis. It is a retrospective case series from a single centre over a period of 5 years. Results: Type II and III tumors were encountered in all the 4 children, who were all less than 3 years of age. Three children underwent neoadjuvant chemotherapy followed by surgical resection, two of whom also completed adjuvant chemotherapy and are on close follow up. The other child relapsed during follow up and the fourth child died during neoadjuvant chemotherapy. Conclusion: The prognosis of this rare tumor has direct association with degree of resection and completion of adjuvant chemotherapy. However, this could be statistically significant only if we could extrapolate it to a study with larger sample size.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Journal of Surgery and Surgical Specialities

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Zhang N, et al. Diagnosis and treatment of pleuropulmonary blastoma in children: A single-centre report of 41 cases. J Pediatr Surg. 2020; 55(7):1351-1355.https://doi.org/10.1016/j.jpedsurg.2019.06.009.
2. Sparber-Sauer M, Seitz G, Kirsch S, Vokuhl C, Leuschner I, Dantonello TM, et al. The impact of local control in the treatment of type II/III pleuropulmonary blastoma. Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS). J Surg Oncol. 2017; 115(2):164172. doi:10.1002/jso.24416.
3. Priest JR, McDermott MB, Bhatia S, Watterson J, Manivel JC, Dehner LP. Pleuropulmonary blastoma.
Cancer. 1997; 80(1):147-161. https://doi.org/10.1002/ (SICI )1097-0142(19970701)80:1<147: :AIDCNCR20> 3.0.CO;2-X.
4. Coran AG, Adzick NS, Krummel TM, Laberge JM, Shamberger RC, Caldamone AA. Pediatric Surgery. 7th ed. Philadelphia: Saunders Elsevier; 2012. p. 569-570.
5. Messinger YH, Stewart DR, Priest JR, Williams GM, Harris AK, Schultz KAP, et al. Pleuropulmonary blastoma: A report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer. 2015; 121(2):276-285. https://doi.org/10.1002/cncr.29032.
6. Polites SF, Heaton TE, LaQuaglia MP, Kim ES, Barry WE, Goodhue CJ, et al. Pneumonectomy for pediatric tumors: A Pediatric Surgical Oncology Research Collaborative study. Ann Surg. 2021; 274(6):e605-e609. https://doi.org/10.1097/SLA.0000000000003795.
7. Pugh TJ, Yu W, Yang J, Field AL, Ambrogio L, Carter SL, et al. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences. Oncogene. 2014; 33(45):52955302. https://doi.org/10.1038/onc.2014.150.
8. Christodoulides N, Fitzmaurice GJ, Bukowska I, O’Rhaillaigh E, Toale C, Griffin M, et al. Postpneumonectomy syndrome: A systematic review of the current evidence and treatment options. J Cardiothorac Surg. 2023; 18(1):119. https://doi.org/10.1186/s13019023-02278-2.
9. Knight S, Knight T, Khan A, Murphy AJ. Current management of pleuropulmonary blastoma: A surgical
perspective. Children (Basel). 2019; 6(8):86. https://doi.org/10.3390/children6080086.
